Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations

Abstract In Peru, 29 292 people were diagnosed with tuberculosis in 2022. Although tuberculosis treatments are effective, 3.4%–13% are associated with significant adverse drug reactions, with drug‐induced liver injury (DILI) considered the most predominant. Among the first‐line antituberculosis drug...

Description complète

Détails bibliographiques

Auteurs principaux:	Luis Jaramillo‐Valverde, Kelly S. Levano, David D. Tarazona, Silvia Capristano, Cesar Sanchez, Julio A. Poterico, Eduardo Tarazona‐Santos, Heinner Guio
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2024-06-01
Collection:	Pharmacology Research & Perspectives
Sujets:	genotype native and mestizo population Pharmacogenetic tuberculosis
Accès en ligne:	https://doi.org/10.1002/prp2.1179
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!